Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 2.340
-0.060 (-2.50%)
Jul 31, 2026, 3:44 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 850.28 million as of July 31, 2026. Its market cap has decreased by -71.04% in one year.
Market Cap
850.28M
Enterprise Value
326.32M
Revenue
374.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.34
ChartMarket Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 850.28M, a decrease of -87.26%. That is a compound annual growth rate of -48.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 850.28M | -48.46% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.29B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.29B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 988.14M |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 839.48M |
| Wuhan YZY Biopharma | 715.30M |